490 likes | 924 Views
. Challenges in Treatment of RA 2010. . . Aiming for remissionand inhibition of structural damage in daily practise. New ACR/EULAR criteria for RA. EULAR Recommendations. Treat 2 Target. New data regarding tocilizumab. Results from Phase IIIb clinical trialsTAMARA, ACT SURE Longterm Safety. .
E N D
32.
33.